Clip thanks to www.pharmacyforall.net A new study led by a federal drug safety expert ties the controversial diabetes drug Avandia (Rosiglitazone) to a higher risk of heart problems, strokes and deaths in older adults, and says it is more dangerous …
Continue reading →
Related Articles: